title: The Treatment of Migraine Headache in the Presence of Selective Serotonin Reuptake Inhibitor Use: Pharmacokinetic Considerations.
authors.affiliation: Questions or comments about this article may be directed to Alyssa Liguori Macca, DNP ARNP-BC, at brainARNP@gmail.com. She is a DNP Graduate, College of Nursing, University of Florida, Gainesville, FL.
authors.forename: Alyssa Liguori
authors.initials: AL
authors.lastname: Macca
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000097:blood / Q000188:drug therapy* / Q000451:nursing*; D015897:Comorbidity; D003577:Cytochrome P-450 Enzyme System / Q000502:physiology; D003866:Depressive Disorder / Q000097:blood / Q000188:drug therapy* / Q000451:nursing*; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000009:adverse effects / Q000451:nursing; D005260:Female; D006801:Humans; D008881:Migraine Disorders / Q000097:blood / Q000188:drug therapy* / Q000451:nursing*; D020230:Serotonin Syndrome / Q000175:diagnosis / Q000451:nursing; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics* / Q000627:therapeutic use*
chemical_list: D003577:Cytochrome P-450 Enzyme System; D017367:Selective Serotonin Reuptake Inhibitors